Hepatitis delta management in the United States: An analysis of All-Payer Claims Data

Evaluating hepatitis delta virus disease prevalence and patient characteristics among adults in the United States: An analysis of an all-payer claims database

Abstract Background and aims Hepatitis delta virus (HDV) infection leads to the most severe form of viral hepatitis and is always associated with hepatitis B virus (HBV) infection. This study estimates the prevalence and describes patient characteristics for...
Hepatitis delta management in the United States: An analysis of All-Payer Claims Data

Increased comorbidity burden among HDV infection vs HBV mono-infection among commercially insured adults in the United States: An All-Payer Claims Database analysis

Abstract BACKGROUND: Hepatitis delta is caused by a defective RNA virus (HDV) that requires the presence of hepatitis B surface antigen for replication and transmission. Compared to hepatitis B virus (HBV) monoinfection, patients with HDV have a greater risk of...
Hepatitis delta management in the United States: An analysis of All-Payer Claims Data

Hepatitis delta among commercially-insured patients in the United States: An analysis of prevalence, patient characteristics and socioeconomic status

Abstract BACKGROUND: Hepatitis delta virus (HDV) requires hepatitis B virus (HBV) for its replication. HDV infection leads to the most severe form of viral hepatitis, which is associated with an increased risk of liver-related morbidity and mortality. HDV prevalence...

Higher baseline comorbidities and liver complications among patients with hepatitis delta infection vs hepatitis B monoinfection: A national US claims database analysis

Abstract Background Hepatitis Delta (HDV/HBV) infection among Hepatitis B (HBV) patients is associated with significant morbidity and mortality. This study compares baseline characteristics of adult patients with HDV/HBV vs Hepatitis B monoinfection (HBV) in a...